Invention Grant
- Patent Title: Crystalline form of 1-(beta-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene and preparation method thereof
-
Application No.: US15003681Application Date: 2016-01-21
-
Publication No.: US10167306B2Publication Date: 2019-01-01
- Inventor: Meng Wang , Liang Zhang
- Applicant: SHANGHAI DESANO PHARMACEUTICALS INVESTMENT CO., LTD , SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD
- Applicant Address: CN Shanghai CN Shanghai
- Assignee: SHANGHAI DESANO PHARMACEUTICALS INVESTMENT CO., LTD.,SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD
- Current Assignee: SHANGHAI DESANO PHARMACEUTICALS INVESTMENT CO., LTD.,SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD
- Current Assignee Address: CN Shanghai CN Shanghai
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Priority: CN201510059262 20150204
- Main IPC: C07H7/04
- IPC: C07H7/04 ; C07D409/10 ; A61K31/381
![Crystalline form of 1-(beta-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene and preparation method thereof](/abs-image/US/2019/01/01/US10167306B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to a crystalline form of 1-(β-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene. Specifically, it discloses a novel crystalline form of 1-(β-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene and the preparation method as well as use thereof. The novel crystalline form of 1-(β-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene provided in the present invention has the advantages such as stable physical and chemical properties, high purity, excellent reproducibility and industrial production suitability.
Public/Granted literature
Information query